Literature DB >> 28695753

Psychosocial Screening Among Youth Seeking Weight Management Treatment.

Megan B Ratcliff1,2, Perry A Catlin3, James L Peugh2, Robert M Siegel2, Shelley Kirk2, Leanne Tamm2.   

Abstract

The objectives of this study were to identify rates of, and factors associated with, "at-risk" scores on a brief psychosocial screener among overweight/obese youth seeking weight management treatment, as well as concordance between youth and caregiver reports. A retrospective chart review of 1443 consecutive patients ages 4 to 18 years and their caregivers was conducted. Almost 1 in 4 youth with overweight/obesity presented with psychosocial symptoms in the at-risk range for significant mental health issues based on caregiver report on the Pediatric Symptom Checklist (PSC) and 1 in 6 based on youth self-report on the Youth Pediatric Symptom Checklist (Y-PSC). Concordance between caregiver and youth was fair (agreement 24% to 40%). Higher scores were associated with male sex and older age on the PSC and with indication of depressive disorder in the electronic medical record on the Y-PSC. Conducting a brief psychosocial screen in comprehensive weight management programs is feasible and clinically indicated.

Entities:  

Keywords:  caregiver; mental health; obesity; overweight; screening

Mesh:

Year:  2017        PMID: 28695753     DOI: 10.1177/0009922817715936

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  2 in total

1.  Impact of Psychosocial Risk on Outcomes among Families Seeking Treatment for Obesity.

Authors:  Thao-Ly T Phan; Fang Fang Chen; Alison Taggi Pinto; Courtney Cox; Jennifer Robbins; Anne E Kazak
Journal:  J Pediatr       Date:  2018-04-05       Impact factor: 4.406

2.  Acceptability of Time-Limited Eating in Pediatric Weight Management.

Authors:  Jared M Tucker; Robert Siegel; Pamela J Murray; Joan C Han; Katherine Boyer; Nichole Reed; Taylor Allenby; Marsha Novick
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-21       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.